Statements (82)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
patent
|
| gptkbp:covers |
biotechnology
|
| gptkbp:hasAbstract |
The invention relates to a method for producing a recombinant protein.
|
| gptkbp:hasAssignee |
gptkb:Biotech_Innovations_Inc.
|
| gptkbp:hasClaim |
20
|
| gptkbp:hasCollaboratedWith |
University_of_Science.
|
| gptkbp:hasCollaborationsWith |
joint research projects.
|
| gptkbp:hasContribution |
contribution to protein science.
|
| gptkbp:hasDescription |
A detailed description of the method and its applications.
|
| gptkbp:hasEducation |
used in academic courses.
|
| gptkbp:hasExaminer |
Jane_Smith
|
| gptkbp:hasExhibition |
Data supporting efficacy.
|
| gptkbp:hasFieldOfUse |
pharmaceuticals
therapeutic proteins |
| gptkbp:hasFilingDate |
2004-02-06
|
| gptkbp:hasFunding |
funded by private investors.
National_Institutes_of_Health. |
| gptkbp:hasGoals |
international collaborations.
|
| gptkbp:hasImpactOn |
biopharmaceutical industry.
|
| gptkbp:hasInfluenceOn |
future biotechnology research.
|
| gptkbp:hasInternationalClassification |
C12N 15/09
|
| gptkbp:hasInventor |
gptkb:Alice_Johnson
gptkb:John_Doe |
| gptkbp:hasLegalEvent |
Maintenance fee paid.
|
| gptkbp:hasLegalStatus |
Active
|
| gptkbp:hasOccupation |
Approved by ethics committee.
FDA_approved. |
| gptkbp:hasParticipatedIn |
advancements in healthcare.
|
| gptkbp:hasPartnershipsWith |
therapeutic agents.
valuable patent. |
| gptkbp:hasPatentNumber |
6,789,800
|
| gptkbp:hasPriorityDate |
2004-09-14
2024-02-06 2003-02-06 |
| gptkbp:hasPublications |
2004-0123456 A1
|
| gptkbp:hasRelatedPatent |
granted patent
potential in gene therapy. US_6,789,799_C27 |
| gptkbp:hasResearchInterest |
molecular biology
vaccine development significant impact on research. Transfection of host cells. |
| gptkbp:hasStudentOrganizations |
E. coli strain.
|
| gptkbp:hasTechnicalField |
genetic engineering
|
| gptkbp:hasTechnology |
Increased yield of protein.
improvements in protein production. |
| gptkbp:hasTitle |
Method for producing a recombinant protein
|
| https://www.w3.org/2000/01/rdf-schema#label |
US 6,789,800 C28
|
| gptkbp:inventiveStep |
Novel method of protein production.
|
| gptkbp:isAssignedTo |
gptkb:Department_of_Patent_and_Trademark_Office
|
| gptkbp:isCitedBy |
gptkb:US_10,000,000_B1
gptkb:US_7,123,456_B2 gptkb:US_8,765,432_B1 research papers. numerous subsequent patents. new biotechnological methods. widely referenced in scientific literature. |
| gptkbp:isCitedIn |
scientific literature
research funding applications. |
| gptkbp:isFiledIn |
gptkb:United_States
|
| gptkbp:isFiledUnder |
gptkb:Biotech_Innovations_Inc.
Utility patent |
| gptkbp:isPartOf |
patent family
intellectual property management. academic-industry partnership. protein engineering. biopharmaceutical innovations. biotech research community. biotechnology industry. biotechnology programs. C28 |
| gptkbp:isPublishedIn |
USPTO database
|
| gptkbp:isReferencedBy |
gptkb:US_9,876,543_B2
|
| gptkbp:isReferencedIn |
biotechnology textbooks.
|
| gptkbp:isRelatedTo |
recombinant DNA technology
biotechnology advancements. |
| gptkbp:isSubjectTo |
patent law.
|
| gptkbp:isUsedIn |
clinical trials.
|
| gptkbp:isUtilizedFor |
biotech companies.
|
| gptkbp:isUtilizedIn |
drug development.
|
| gptkbp:market |
high demand for therapeutic proteins.
|
| gptkbp:usesTechnology |
protein expression systems
|